Cargando…
Combination of PET and CXCR4-Targeted Peptide Molecule Agents for Noninvasive Tumor Monitoring
Precision medicine is emphasizing not only at individual but also at disease molecule level in modern medicine. Therefore, target-specific molecular agents are crucial for precise diagnosis and treatment. We developed a peptide agent that binds a critical chemokine receptor-CXCR4 and could be used t...
Autores principales: | Lin, Yizi, Lin, Yi, Lin, Xiao, Sun, Xiaotian, Luo, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603417/ https://www.ncbi.nlm.nih.gov/pubmed/31293645 http://dx.doi.org/10.7150/jca.31087 |
Ejemplares similares
-
Therapy-Induced Changes in CXCR4 Expression in Tumor Xenografts Can Be Monitored Noninvasively with N-[(11)C]Methyl-AMD3465 PET
por: Hartimath, SV, et al.
Publicado: (2019) -
New imaging agents targeting chemokine receptor CXCR4 for PET/SPECT and MRI
por: Poty, Sophie, et al.
Publicado: (2014) -
Reducing the Kidney Uptake of High Contrast CXCR4 PET Imaging Agents via Linker Modifications
por: Kwon, Daniel, et al.
Publicado: (2022) -
Peptide-based PET imaging agent of tumor TIGIT expression
por: Weng, Dinghu, et al.
Publicado: (2023) -
PET imaging of CXCR4 using copper-64 labeled peptide antagonist
por: Jacobson, Orit, et al.
Publicado: (2011)